The global market for Valganciclovir API is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Valganciclovir API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Valganciclovir API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Valganciclovir API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Valganciclovir API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Valganciclovir API players cover Biophore India Pharmaceuticals Pvt Ltd, Mylan, Extrovis AG, Aurore Life Sciences and Hetero Drugs, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Valganciclovir API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Valganciclovir API market, with both quantitative and qualitative data, to help readers understand how the Valganciclovir API market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Kg.
Market Segmentation:
The study segments the Valganciclovir API market and forecasts the market size by Purity (Above 98 % and Above 99 %,), by Application (Tablets, Oral Solution and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by purity
Above 98 %
Above 99 %
Segmentation by application
Tablets
Oral Solution
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Biophore India Pharmaceuticals Pvt Ltd
Mylan
Extrovis AG
Aurore Life Sciences
Hetero Drugs
Calyx Chemicals & Pharmaceuticals Limited
DEAFARMA
Aspire Lifesciences Pvt Ltd
Rakshit Drugs
Anthem Biosciences
Hanways Chempharm Co., Limited
Chapter Introduction
Chapter 1: Scope of Valganciclovir API, Research Methodology, etc.
Chapter 2: Executive Summary, global Valganciclovir API market size (sales and revenue) and CAGR, Valganciclovir API market size by region, by purity, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Valganciclovir API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Valganciclovir API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by purity, and purity.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Valganciclovir API market size forecast by region, by country, by purity, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Biophore India Pharmaceuticals Pvt Ltd, Mylan, Extrovis AG, Aurore Life Sciences, Hetero Drugs, Calyx Chemicals & Pharmaceuticals Limited, DEAFARMA, Aspire Lifesciences Pvt Ltd and Rakshit Drugs, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Valganciclovir API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Valganciclovir API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Valganciclovir API by Country/Region, 2017, 2022 & 2028
2.2 Valganciclovir API Segment by Purity
2.2.1 Above 98 %
2.2.2 Above 99 %
2.3 Valganciclovir API Sales by Purity
2.3.1 Global Valganciclovir API Sales Market Share by Purity (2017-2022)
2.3.2 Global Valganciclovir API Revenue and Market Share by Purity (2017-2022)
2.3.3 Global Valganciclovir API Sale Price by Purity (2017-2022)
2.4 Valganciclovir API Segment by Application
2.4.1 Tablets
2.4.2 Oral Solution
2.4.3 Others
2.5 Valganciclovir API Sales by Application
2.5.1 Global Valganciclovir API Sale Market Share by Application (2017-2022)
2.5.2 Global Valganciclovir API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Valganciclovir API Sale Price by Application (2017-2022)
3 Global Valganciclovir API by Company
3.1 Global Valganciclovir API Breakdown Data by Company
3.1.1 Global Valganciclovir API Annual Sales by Company (2020-2022)
3.1.2 Global Valganciclovir API Sales Market Share by Company (2020-2022)
3.2 Global Valganciclovir API Annual Revenue by Company (2020-2022)
3.2.1 Global Valganciclovir API Revenue by Company (2020-2022)
3.2.2 Global Valganciclovir API Revenue Market Share by Company (2020-2022)
3.3 Global Valganciclovir API Sale Price by Company
3.4 Key Manufacturers Valganciclovir API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Valganciclovir API Product Location Distribution
3.4.2 Players Valganciclovir API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Valganciclovir API by Geographic Region
4.1 World Historic Valganciclovir API Market Size by Geographic Region (2017-2022)
4.1.1 Global Valganciclovir API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Valganciclovir API Annual Revenue by Geographic Region
4.2 World Historic Valganciclovir API Market Size by Country/Region (2017-2022)
4.2.1 Global Valganciclovir API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Valganciclovir API Annual Revenue by Country/Region
4.3 Americas Valganciclovir API Sales Growth
4.4 APAC Valganciclovir API Sales Growth
4.5 Europe Valganciclovir API Sales Growth
4.6 Middle East & Africa Valganciclovir API Sales Growth
5 Americas
5.1 Americas Valganciclovir API Sales by Country
5.1.1 Americas Valganciclovir API Sales by Country (2017-2022)
5.1.2 Americas Valganciclovir API Revenue by Country (2017-2022)
5.2 Americas Valganciclovir API Sales by Purity
5.3 Americas Valganciclovir API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Valganciclovir API Sales by Region
6.1.1 APAC Valganciclovir API Sales by Region (2017-2022)
6.1.2 APAC Valganciclovir API Revenue by Region (2017-2022)
6.2 APAC Valganciclovir API Sales by Purity
6.3 APAC Valganciclovir API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Valganciclovir API by Country
7.1.1 Europe Valganciclovir API Sales by Country (2017-2022)
7.1.2 Europe Valganciclovir API Revenue by Country (2017-2022)
7.2 Europe Valganciclovir API Sales by Purity
7.3 Europe Valganciclovir API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Valganciclovir API by Country
8.1.1 Middle East & Africa Valganciclovir API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Valganciclovir API Revenue by Country (2017-2022)
8.2 Middle East & Africa Valganciclovir API Sales by Purity
8.3 Middle East & Africa Valganciclovir API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Valganciclovir API
10.3 Manufacturing Process Analysis of Valganciclovir API
10.4 Industry Chain Structure of Valganciclovir API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Valganciclovir API Distributors
11.3 Valganciclovir API Customer
12 World Forecast Review for Valganciclovir API by Geographic Region
12.1 Global Valganciclovir API Market Size Forecast by Region
12.1.1 Global Valganciclovir API Forecast by Region (2023-2028)
12.1.2 Global Valganciclovir API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Valganciclovir API Forecast by Purity
12.7 Global Valganciclovir API Forecast by Application
13 Key Players Analysis
13.1 Biophore India Pharmaceuticals Pvt Ltd
13.1.1 Biophore India Pharmaceuticals Pvt Ltd Company Information
13.1.2 Biophore India Pharmaceuticals Pvt Ltd Valganciclovir API Product Offered
13.1.3 Biophore India Pharmaceuticals Pvt Ltd Valganciclovir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Biophore India Pharmaceuticals Pvt Ltd Main Business Overview
13.1.5 Biophore India Pharmaceuticals Pvt Ltd Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Valganciclovir API Product Offered
13.2.3 Mylan Valganciclovir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Extrovis AG
13.3.1 Extrovis AG Company Information
13.3.2 Extrovis AG Valganciclovir API Product Offered
13.3.3 Extrovis AG Valganciclovir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Extrovis AG Main Business Overview
13.3.5 Extrovis AG Latest Developments
13.4 Aurore Life Sciences
13.4.1 Aurore Life Sciences Company Information
13.4.2 Aurore Life Sciences Valganciclovir API Product Offered
13.4.3 Aurore Life Sciences Valganciclovir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Aurore Life Sciences Main Business Overview
13.4.5 Aurore Life Sciences Latest Developments
13.5 Hetero Drugs
13.5.1 Hetero Drugs Company Information
13.5.2 Hetero Drugs Valganciclovir API Product Offered
13.5.3 Hetero Drugs Valganciclovir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hetero Drugs Main Business Overview
13.5.5 Hetero Drugs Latest Developments
13.6 Calyx Chemicals & Pharmaceuticals Limited
13.6.1 Calyx Chemicals & Pharmaceuticals Limited Company Information
13.6.2 Calyx Chemicals & Pharmaceuticals Limited Valganciclovir API Product Offered
13.6.3 Calyx Chemicals & Pharmaceuticals Limited Valganciclovir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Calyx Chemicals & Pharmaceuticals Limited Main Business Overview
13.6.5 Calyx Chemicals & Pharmaceuticals Limited Latest Developments
13.7 DEAFARMA
13.7.1 DEAFARMA Company Information
13.7.2 DEAFARMA Valganciclovir API Product Offered
13.7.3 DEAFARMA Valganciclovir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 DEAFARMA Main Business Overview
13.7.5 DEAFARMA Latest Developments
13.8 Aspire Lifesciences Pvt Ltd
13.8.1 Aspire Lifesciences Pvt Ltd Company Information
13.8.2 Aspire Lifesciences Pvt Ltd Valganciclovir API Product Offered
13.8.3 Aspire Lifesciences Pvt Ltd Valganciclovir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Aspire Lifesciences Pvt Ltd Main Business Overview
13.8.5 Aspire Lifesciences Pvt Ltd Latest Developments
13.9 Rakshit Drugs
13.9.1 Rakshit Drugs Company Information
13.9.2 Rakshit Drugs Valganciclovir API Product Offered
13.9.3 Rakshit Drugs Valganciclovir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Rakshit Drugs Main Business Overview
13.9.5 Rakshit Drugs Latest Developments
13.10 Anthem Biosciences
13.10.1 Anthem Biosciences Company Information
13.10.2 Anthem Biosciences Valganciclovir API Product Offered
13.10.3 Anthem Biosciences Valganciclovir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Anthem Biosciences Main Business Overview
13.10.5 Anthem Biosciences Latest Developments
13.11 Hanways Chempharm Co., Limited
13.11.1 Hanways Chempharm Co., Limited Company Information
13.11.2 Hanways Chempharm Co., Limited Valganciclovir API Product Offered
13.11.3 Hanways Chempharm Co., Limited Valganciclovir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hanways Chempharm Co., Limited Main Business Overview
13.11.5 Hanways Chempharm Co., Limited Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Valganciclovir API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Valganciclovir API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Above 98 %
Table 4. Major Players of Above 99 %
Table 5. Global Valganciclovir API Sales by Purity (2017-2022) & (Kg)
Table 6. Global Valganciclovir API Sales Market Share by Purity (2017-2022)
Table 7. Global Valganciclovir API Revenue by Purity (2017-2022) & ($ million)
Table 8. Global Valganciclovir API Revenue Market Share by Purity (2017-2022)
Table 9. Global Valganciclovir API Sale Price by Purity (2017-2022) & (US$/Kg)
Table 10. Global Valganciclovir API Sales by Application (2017-2022) & (Kg)
Table 11. Global Valganciclovir API Sales Market Share by Application (2017-2022)
Table 12. Global Valganciclovir API Revenue by Application (2017-2022)
Table 13. Global Valganciclovir API Revenue Market Share by Application (2017-2022)
Table 14. Global Valganciclovir API Sale Price by Application (2017-2022) & (US$/Kg)
Table 15. Global Valganciclovir API Sales by Company (2020-2022) & (Kg)
Table 16. Global Valganciclovir API Sales Market Share by Company (2020-2022)
Table 17. Global Valganciclovir API Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Valganciclovir API Revenue Market Share by Company (2020-2022)
Table 19. Global Valganciclovir API Sale Price by Company (2020-2022) & (US$/Kg)
Table 20. Key Manufacturers Valganciclovir API Producing Area Distribution and Sales Area
Table 21. Players Valganciclovir API Products Offered
Table 22. Valganciclovir API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Valganciclovir API Sales by Geographic Region (2017-2022) & (Kg)
Table 26. Global Valganciclovir API Sales Market Share Geographic Region (2017-2022)
Table 27. Global Valganciclovir API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Valganciclovir API Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Valganciclovir API Sales by Country/Region (2017-2022) & (Kg)
Table 30. Global Valganciclovir API Sales Market Share by Country/Region (2017-2022)
Table 31. Global Valganciclovir API Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Valganciclovir API Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Valganciclovir API Sales by Country (2017-2022) & (Kg)
Table 34. Americas Valganciclovir API Sales Market Share by Country (2017-2022)
Table 35. Americas Valganciclovir API Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Valganciclovir API Revenue Market Share by Country (2017-2022)
Table 37. Americas Valganciclovir API Sales by Type (2017-2022) & (Kg)
Table 38. Americas Valganciclovir API Sales Market Share by Purity (2017-2022)
Table 39. Americas Valganciclovir API Sales by Application (2017-2022) & (Kg)
Table 40. Americas Valganciclovir API Sales Market Share by Application (2017-2022)
Table 41. APAC Valganciclovir API Sales by Region (2017-2022) & (Kg)
Table 42. APAC Valganciclovir API Sales Market Share by Region (2017-2022)
Table 43. APAC Valganciclovir API Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Valganciclovir API Revenue Market Share by Region (2017-2022)
Table 45. APAC Valganciclovir API Sales by Purity (2017-2022) & (Kg)
Table 46. APAC Valganciclovir API Sales Market Share by Purity (2017-2022)
Table 47. APAC Valganciclovir API Sales by Application (2017-2022) & (Kg)
Table 48. APAC Valganciclovir API Sales Market Share by Application (2017-2022)
Table 49. Europe Valganciclovir API Sales by Country (2017-2022) & (Kg)
Table 50. Europe Valganciclovir API Sales Market Share by Country (2017-2022)
Table 51. Europe Valganciclovir API Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Valganciclovir API Revenue Market Share by Country (2017-2022)
Table 53. Europe Valganciclovir API Sales by Type (2017-2022) & (Kg)
Table 54. Europe Valganciclovir API Sales Market Share by Purity (2017-2022)
Table 55. Europe Valganciclovir API Sales by Application (2017-2022) & (Kg)
Table 56. Europe Valganciclovir API Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Valganciclovir API Sales by Country (2017-2022) & (Kg)
Table 58. Middle East & Africa Valganciclovir API Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Valganciclovir API Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Valganciclovir API Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Valganciclovir API Sales by Purity (2017-2022) & (Kg)
Table 62. Middle East & Africa Valganciclovir API Sales Market Share by Purity (2017-2022)
Table 63. Middle East & Africa Valganciclovir API Sales by Application (2017-2022) & (Kg)
Table 64. Middle East & Africa Valganciclovir API Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Valganciclovir API
Table 66. Key Market Challenges & Risks of Valganciclovir API
Table 67. Key Industry Trends of Valganciclovir API
Table 68. Valganciclovir API Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Valganciclovir API Distributors List
Table 71. Valganciclovir API Customer List
Table 72. Global Valganciclovir API Sales Forecast by Region (2023-2028) & (Kg)
Table 73. Global Valganciclovir API Sales Market Forecast by Region
Table 74. Global Valganciclovir API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Valganciclovir API Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Valganciclovir API Sales Forecast by Country (2023-2028) & (Kg)
Table 77. Americas Valganciclovir API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Valganciclovir API Sales Forecast by Region (2023-2028) & (Kg)
Table 79. APAC Valganciclovir API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Valganciclovir API Sales Forecast by Country (2023-2028) & (Kg)
Table 81. Europe Valganciclovir API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Valganciclovir API Sales Forecast by Country (2023-2028) & (Kg)
Table 83. Middle East & Africa Valganciclovir API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Valganciclovir API Sales Forecast by Purity (2023-2028) & (Kg)
Table 85. Global Valganciclovir API Sales Market Share Forecast by Purity (2023-2028)
Table 86. Global Valganciclovir API Revenue Forecast by Purity (2023-2028) & ($ Millions)
Table 87. Global Valganciclovir API Revenue Market Share Forecast by Purity (2023-2028)
Table 88. Global Valganciclovir API Sales Forecast by Application (2023-2028) & (Kg)
Table 89. Global Valganciclovir API Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Valganciclovir API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Valganciclovir API Revenue Market Share Forecast by Application (2023-2028)
Table 92. Biophore India Pharmaceuticals Pvt Ltd Basic Information, Valganciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 93. Biophore India Pharmaceuticals Pvt Ltd Valganciclovir API Product Offered
Table 94. Biophore India Pharmaceuticals Pvt Ltd Valganciclovir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 95. Biophore India Pharmaceuticals Pvt Ltd Main Business
Table 96. Biophore India Pharmaceuticals Pvt Ltd Latest Developments
Table 97. Mylan Basic Information, Valganciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 98. Mylan Valganciclovir API Product Offered
Table 99. Mylan Valganciclovir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 100. Mylan Main Business
Table 101. Mylan Latest Developments
Table 102. Extrovis AG Basic Information, Valganciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 103. Extrovis AG Valganciclovir API Product Offered
Table 104. Extrovis AG Valganciclovir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 105. Extrovis AG Main Business
Table 106. Extrovis AG Latest Developments
Table 107. Aurore Life Sciences Basic Information, Valganciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 108. Aurore Life Sciences Valganciclovir API Product Offered
Table 109. Aurore Life Sciences Valganciclovir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 110. Aurore Life Sciences Main Business
Table 111. Aurore Life Sciences Latest Developments
Table 112. Hetero Drugs Basic Information, Valganciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 113. Hetero Drugs Valganciclovir API Product Offered
Table 114. Hetero Drugs Valganciclovir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 115. Hetero Drugs Main Business
Table 116. Hetero Drugs Latest Developments
Table 117. Calyx Chemicals & Pharmaceuticals Limited Basic Information, Valganciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 118. Calyx Chemicals & Pharmaceuticals Limited Valganciclovir API Product Offered
Table 119. Calyx Chemicals & Pharmaceuticals Limited Valganciclovir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 120. Calyx Chemicals & Pharmaceuticals Limited Main Business
Table 121. Calyx Chemicals & Pharmaceuticals Limited Latest Developments
Table 122. DEAFARMA Basic Information, Valganciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 123. DEAFARMA Valganciclovir API Product Offered
Table 124. DEAFARMA Valganciclovir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 125. DEAFARMA Main Business
Table 126. DEAFARMA Latest Developments
Table 127. Aspire Lifesciences Pvt Ltd Basic Information, Valganciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 128. Aspire Lifesciences Pvt Ltd Valganciclovir API Product Offered
Table 129. Aspire Lifesciences Pvt Ltd Valganciclovir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 130. Aspire Lifesciences Pvt Ltd Main Business
Table 131. Aspire Lifesciences Pvt Ltd Latest Developments
Table 132. Rakshit Drugs Basic Information, Valganciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 133. Rakshit Drugs Valganciclovir API Product Offered
Table 134. Rakshit Drugs Valganciclovir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 135. Rakshit Drugs Main Business
Table 136. Rakshit Drugs Latest Developments
Table 137. Anthem Biosciences Basic Information, Valganciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 138. Anthem Biosciences Valganciclovir API Product Offered
Table 139. Anthem Biosciences Valganciclovir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 140. Anthem Biosciences Main Business
Table 141. Anthem Biosciences Latest Developments
Table 142. Hanways Chempharm Co., Limited Basic Information, Valganciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 143. Hanways Chempharm Co., Limited Valganciclovir API Product Offered
Table 144. Hanways Chempharm Co., Limited Valganciclovir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 145. Hanways Chempharm Co., Limited Main Business
Table 146. Hanways Chempharm Co., Limited Latest Developments
List of Figures
Figure 1. Picture of Valganciclovir API
Figure 2. Valganciclovir API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Valganciclovir API Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Valganciclovir API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Valganciclovir API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Above 98 %
Figure 10. Product Picture of Above 99 %
Figure 11. Global Valganciclovir API Sales Market Share by Purity in 2021
Figure 12. Global Valganciclovir API Revenue Market Share by Purity (2017-2022)
Figure 13. Valganciclovir API Consumed in Tablets
Figure 14. Global Valganciclovir API Market: Tablets (2017-2022) & (Kg)
Figure 15. Valganciclovir API Consumed in Oral Solution
Figure 16. Global Valganciclovir API Market: Oral Solution (2017-2022) & (Kg)
Figure 17. Valganciclovir API Consumed in Others
Figure 18. Global Valganciclovir API Market: Others (2017-2022) & (Kg)
Figure 19. Global Valganciclovir API Sales Market Share by Application (2017-2022)
Figure 20. Global Valganciclovir API Revenue Market Share by Application in 2021
Figure 21. Valganciclovir API Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Valganciclovir API Revenue Market Share by Company in 2021
Figure 23. Global Valganciclovir API Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Valganciclovir API Revenue Market Share by Geographic Region in 2021
Figure 25. Global Valganciclovir API Sales Market Share by Region (2017-2022)
Figure 26. Global Valganciclovir API Revenue Market Share by Country/Region in 2021
Figure 27. Americas Valganciclovir API Sales 2017-2022 (Kg)
Figure 28. Americas Valganciclovir API Revenue 2017-2022 ($ Millions)
Figure 29. APAC Valganciclovir API Sales 2017-2022 (Kg)
Figure 30. APAC Valganciclovir API Revenue 2017-2022 ($ Millions)
Figure 31. Europe Valganciclovir API Sales 2017-2022 (Kg)
Figure 32. Europe Valganciclovir API Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Valganciclovir API Sales 2017-2022 (Kg)
Figure 34. Middle East & Africa Valganciclovir API Revenue 2017-2022 ($ Millions)
Figure 35. Americas Valganciclovir API Sales Market Share by Country in 2021
Figure 36. Americas Valganciclovir API Revenue Market Share by Country in 2021
Figure 37. United States Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Valganciclovir API Sales Market Share by Region in 2021
Figure 42. APAC Valganciclovir API Revenue Market Share by Regions in 2021
Figure 43. China Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Valganciclovir API Sales Market Share by Country in 2021
Figure 50. Europe Valganciclovir API Revenue Market Share by Country in 2021
Figure 51. Germany Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Valganciclovir API Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Valganciclovir API Revenue Market Share by Country in 2021
Figure 58. Egypt Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Valganciclovir API Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Valganciclovir API in 2021
Figure 64. Manufacturing Process Analysis of Valganciclovir API
Figure 65. Industry Chain Structure of Valganciclovir API
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Global Graphitized Carbon Black (GCB) Ma..
Graphitized carbon black is a black particle that can be use..
+16467917070US (Toll Free)